Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152,309,909
-
Number of holders
-
542
-
Total 13F shares, excl. options
-
148,715,946
-
Shares change
-
-1,250,890
-
Total reported value, excl. options
-
$11,031,044,107
-
Value change
-
-$125,004,989
-
Put/Call ratio
-
40%
-
Number of buys
-
274
-
Number of sells
-
-239
-
Price
-
$74.19
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q1 2023
612 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q1 2023.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 542 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 148,715,946 shares
of 152,309,909 outstanding shares and own 98% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (18,431,453 shares), BlackRock Inc. (15,994,625 shares), STATE STREET CORP (6,278,066 shares), Select Equity Group, L.P. (5,640,897 shares), BAMCO INC /NY/ (5,379,492 shares), Neuberger Berman Group LLC (4,050,615 shares), GEODE CAPITAL MANAGEMENT, LLC (3,741,171 shares), BROWN CAPITAL MANAGEMENT LLC (3,262,377 shares), MORGAN STANLEY (3,184,182 shares), and WELLINGTON MANAGEMENT GROUP LLP (3,079,295 shares).
This table shows the top 542 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.